BOSTON SCIENTIFIC CORP Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Boston Scientific Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Boston Scientific Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $200M, a 90.5% increase year-over-year.
  • Boston Scientific Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $414M, a 36.1% decline year-over-year.
  • Boston Scientific Corp annual Income Tax Expense (Benefit) for 2023 was $393M, a 11.3% decline from 2022.
  • Boston Scientific Corp annual Income Tax Expense (Benefit) for 2022 was $443M, a 1131% increase from 2021.
  • Boston Scientific Corp annual Income Tax Expense (Benefit) for 2021 was $36M, a 1700% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $414M $200M +$95M +90.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-01
Q2 2024 $319M $98M -$58M -37.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $377M $115M -$16M -12.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $393M $1M -$255M -99.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $648M $105M +$48M +84.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 $600M $156M +$71M +83.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $529M $131M +$86M +191% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $443M $256M +$231M +924% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $212M $57M -$7M -10.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $219M $85M +$122M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $97M $45M +$61M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $36M $25M -$70M -73.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $106M $64M +$136M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$30M -$37M -$4M -12.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$26M -$16M -$28M -233% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $2M $95M +$4.1B Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$4.1B -$72M -$37M -106% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$4.06B -$33M -$24M -267% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$4.03B $12M -$21M -63.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$4.01B -$4B -$3.91B -4347% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 -$101M -$35M -$59M -246% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$42M -$9M +$200M +95.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$242M $33M +$7M +26.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$249M -$90M -$932M -111% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $683M $24M -$2M -7.69% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $685M -$209M -$154M -280% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 $839M $26M +$11M +73.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $828M $842M +$877M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 -$49M $26M -$3M -10.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 -$46M -$55M +$135M +71.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 -$181M $15M -$11M -42.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 -$170M -$35M +$160M +82.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-19
Q3 2016 -$330M $29M +$198M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$528M -$190M -$193M -6433% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$335M $26M +$76M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$411M -$195M +$60M +23.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-20
Q3 2015 -$471M -$169M -$129M -323% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$342M $3M +$111M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$453M -$50M -$63M -485% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 -$390M -$255M -$206M -420% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 -$184M -$40M -$5M -14.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$179M -$108M -$130M -591% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$49M $13M +$53M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 -$102M -$49M -$39M -390% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-24
Q3 2013 -$63M -$35M -$36M -3600% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$27M $22M +$62M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$89M -$40M -$50M -500% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$39M -$10M -$3M -42.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 -$36M $1M +$32M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 -$68M -$40M -$52M -433% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$16M $10M -$217M -95.6% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-05-07
Q4 2011 $201M -$7M -$1M -16.7% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 $202M -$31M -$4M -14.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $206M $12M -$9M -42.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $215M $227M +$213M +1521% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
Q4 2010 $2M -$6M Oct 1, 2010 Dec 31, 2010 8-K 2013-05-29
Q3 2010 -$27M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $21M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 $14M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.